HP
Insider selling
Hendrik Peter Scholl sold $1.5M of Belite Bio, Inc (BLTE) stock
Hendrik Peter Scholl, Chief Medical Officer of Belite Bio, Inc (BLTE), sold 10,000 shares of BLTE stock worth $1.5M, per an SEC Form 4 filed Jun 22, 2026.
It was an open-market sale.
The trade happened on Jun 18, 2026, 4 days before it was made public.
BLTE has moved +18.7% since the trade date, from $146.12 to $173.40 (Sep 21, 2026 close).
- Traded
- Jun 18, 2026
- Disclosed
- Jun 22, 2026
- Filing delay
- 4 days
- Price since
- +18.7%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More BLTE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.